Insects pose a major challenge to the health of crops worldwide, directly injuring plants as they feed on the plant's stems, fruit and roots, as well as indirectly by transmitting bacterial, viral and fungal infections to crops - costing the global economy an estimated $70 billion a year, according to the UN's Food and Agriculture Organization[1]. Experts predict such losses will worsen with global warming widening the spread of invasive insect risk and rising resistance to available insecticides. "Syngenta ...

The probiotics market is expected to double and reach approximately $114 billion by 2031 from approximately $55 billion in 2022[i]. The increased awareness of the microbiome, the bacteria living in and on the human body, has sparked significant interest in microbiome products based on supporting microbes for a healthier lifestyle. This collaboration aligns with the expanding importance of global microbiome research. The collaboration generates excellent synergy by combining Evogene's knowledge in bacterial- ...

Nir Arbel - CPO of Evogene Ofer Haviv Thank you, and good day, everyone. Today, I will review Evogene's activities, our financial stabilities and recent achievements. I will also provide an update on Evogene's potential catalyst expected in the near future. I will discuss some of our subsidiaries recent accomplishments and their positive impact on Evogene. Bear in mind that our subsidiaries leverage evidence technology as their main competitive advantage and their accomplishments demonstrate the power and t ...

Company Participants All forward-looking statements made herein speak only as of the date of the announcement of results. Many of the factors that impact whether forward-looking statements will come true are beyond the control of Evogene and may cause actual results to differ materially from anticipated results. We continued significant investment in Evogene ChemPass AI tech engine to strongly position us to forge strategic partnerships with industry leaders, expediting product development and delivering no ...

Company Participants Elran Haber - CEO, Biomica Ltd Ben Klieve - Lake Street Capital Markets Before we begin, I would like to caution that certain statements made during this earnings conference call by evidence management will constitute forward-looking statements that relate to future events, risks and uncertainties regarding business, strategy, operations and future performance and results of Evergene. All forward-looking statements made herein speak only as of the date of the announcement of results. Ma ...

Exhibit 99.2 EVOGENE LTD. 13 Gad Feinstein St., Park Rehovot P.O.B. 4173, Ness Ziona, 7414003, Israel PROXY STATEMENT 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS This Proxy Statement is being furnished in connection with the solicitation of proxies on behalf of the Board of Directors, or the Board, of Evogene Ltd., to which we refer as Evogene or the Company, to be voted at the 2023 Annual General Meeting of Shareholders of the Company, or the Meeting, and at any adjournment thereof, pursuant to the Notice ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F | ☐ | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 | | --- | --- | | | OR | | ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the fiscal year ended December 31, 2022 | | | OR | | ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | OR | | ☐ | SHELL COMPANY REPORT PURSUANT TO SECTION ...

Evogene Ltd. (NASDAQ:EVGN) Q4 2022 Earnings Conference Call March 9, 2023 9:00 AM ET Company Participants Ofer Haviv - Chief Executive Officer Eyal Ronen - Executive Vice President, Business Development Yaron Eldad - Chief Financial Officer Conference Call Participants Kristen Kluska - Cantor Fitzgerald Brett Reiss - Janney Montgomery Scott Brian Wright - ROTH Capital Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene’s Fourth Quarter and Full Year 2022 Results Conference Call. All ...

Start Time: 09:00 January 1, 0000 9:34 AM ET Evogene Ltd. (NASDAQ:EVGN) Q3 2022 Earnings Conference Call November 17, 2022, 09:00 AM ET Company Participants Ofer Haviv - President and CEO Yaron Eldad - CFO Conference Call Participants Kristen Kluska - Cantor Fitzgerald Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene's Third Quarter 2022 Results Conference Call. All participants are at present in listen-only mode. Following management's formal presentation, instructions will be g ...

Evogene Ltd. (NASDAQ:EVGN) Q2 2022 Earnings Conference Call August 31, 2022 9:00 AM ET Â Company Participants Ofer Haviv - President & CEO Russ Putland - EVP Commercial & General Manager, Lavie-Bio, Inc. Yaron Eldad - CFO Conference Call Participants Kristen Kluska - Cantor Fitzgerald Brian Wright - ROTH Capital Partners Brett Reiss - Janney Montgomery Scott Operator Ladies and gentlemen, thank you for standing by. Welcome to Evogene's Second Quarter 2022 Results Conference Call. All participants are presen ...